Sponsor pipeline

Peking University International Hospital clinical trial pipeline

Get alerts when Peking University International Hospital's trials change

3 active trials 1 recruiting 1 Phase 3 1 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 2/3
1
Phase 4
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials

NCT IDTitleConditionStatusUpdated
Phase 4
NCT05844813 Neoadjuvant Chemotherapy Combined With Targeted Treatment in High-risk Retroperitoneal… Retroperitoneal Sarcoma Enrolling by Invitation 2023-05-12
Phase 2/3
NCT04047576 Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis Retroperitoneal Fibrosis Recruiting 2025-06-04
Not applicable
NCT05746689 Study of Sirolimus in IgG4-related Disease IgG4-related Disease Not Yet Recruiting 2023-02-28

Disease areas by active trials

Sarcoma (1)

Get alerts when Peking University International Hospital's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free